| Trial Identifier: | D6830C00005 |
| Sponsor: | AstraZeneca |
| Start Date: | June 2025 |
| Primary Completion Date: | September 2025 |
| Study Completion Date: | September 2025 |
| Condition: | Asthma |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Version |
| Country | Location |
|---|---|
| United States of America, CA | Bakersfield, CA, United States of America, 93301 |
| United States of America, FL | Miami Lakes, FL, United States of America, 33014 |
| United States of America, LA | Lafayette, LA, United States of America, 70508 |
| United States of America, NC | Raleigh, NC, United States of America, 27607 |
| United States of America, OH | Toledo, OH, United States of America, 43617 |
| United States of America, OK | Oklahoma City, OK, United States of America, 73120 |
| United States of America, SC | Spartanburg, SC, United States of America, 29303 |
| United States of America, TX | Boerne, TX, United States of America, 78006 |
| United States of America, UT | Salt Lake City, UT, United States of America, 84107 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2026 Pharma Intelligence UK Limited (Citeline), a Norstella company